130 related articles for article (PubMed ID: 36241545)
1. Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy.
Tan WS; Koelker M; Campain N; Cole AP; Labban M; Mossanen M; Barod R; Kibel AS; Chang SL; Bex A; Trinh QD
Eur Urol Focus; 2023 Mar; 9(2):333-335. PubMed ID: 36241545
[TBL] [Abstract][Full Text] [Related]
2. Utilization and quality outcomes of cT1a, cT1b and cT2a partial nephrectomy: analysis of the national cancer database.
Fero K; Hamilton ZA; Bindayi A; Murphy JD; Derweesh IH
BJU Int; 2018 Apr; 121(4):565-574. PubMed ID: 29032581
[TBL] [Abstract][Full Text] [Related]
3. Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer Database.
Ryan ST; Patel DN; Ghali F; Patel SH; Sarkar R; Yim K; Eldefrawy A; Cotta BH; Bradshaw AW; Meagher MF; Hamilton ZA; Murphy JD; Derweesh IH
Minerva Urol Nephrol; 2021 Apr; 73(2):233-244. PubMed ID: 32748614
[TBL] [Abstract][Full Text] [Related]
4. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
5. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
[TBL] [Abstract][Full Text] [Related]
6. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis.
Yim K; Aron M; Rha KH; Simone G; Minervini A; Challacombe B; Schips L; Berardinelli F; Quarto G; Mehrazin R; Patel D; Patel S; Bindayi A; Ashrafi AN; Desai M; Alqahtani A; Gallucci M; Sulek J; Mari A; De Luyk N; Anele U; Autorino R; Porpiglia F; Sundaram CP; Gill IS; Perdona S; Derweesh IH
Eur Urol Focus; 2021 Sep; 7(5):1107-1114. PubMed ID: 33249089
[TBL] [Abstract][Full Text] [Related]
8. Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis.
Yanagisawa T; Mori K; Kawada T; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Pradere B; Miki J; Kimura T; Egawa S; Shariat SF
Urol Oncol; 2022 Jul; 40(7):315-330. PubMed ID: 35562311
[TBL] [Abstract][Full Text] [Related]
9. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
10. Robot-assisted partial nephrectomy for large renal masses: a multi-institutional series.
Delto JC; Paulucci D; Helbig MW; Badani KK; Eun D; Porter J; Abaza R; Hemal AK; Bhandari A
BJU Int; 2018 Jun; 121(6):908-915. PubMed ID: 29357404
[TBL] [Abstract][Full Text] [Related]
11. Comparison of perioperative outcomes of robot-assisted partial nephrectomy without renorrhaphy: Comparative outcomes of cT1a versus cT1b renal tumors.
Tohi Y; Murata S; Makita N; Suzuki I; Kubota M; Sugino Y; Inoue K; Kawakita M
Int J Urol; 2019 Sep; 26(9):885-889. PubMed ID: 31257682
[TBL] [Abstract][Full Text] [Related]
12. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
13. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
14. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
15. The long-term outcomes of local tumor destruction versus partial nephrectomy for cT1a non-clear cell renal cell carcinoma and development of prognostic nomograms.
Qiu J; Deng R; Zhao Z; Tian P; Zhou J
J Cancer Res Clin Oncol; 2024 Mar; 150(3):122. PubMed ID: 38472549
[TBL] [Abstract][Full Text] [Related]
16. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.
Sterling J; Rivera-Núñez Z; Patel HV; Farber NJ; Kim S; Radadia KD; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Clin Genitourin Cancer; 2020 Dec; 18(6):e643-e650. PubMed ID: 32389458
[TBL] [Abstract][Full Text] [Related]
18. Impact of positive surgical margins on overall survival after partial nephrectomy-A matched comparison based on the National Cancer Database.
Shum CF; Bahler CD; Sundaram CP
Urol Oncol; 2018 Mar; 36(3):90.e15-90.e21. PubMed ID: 29223360
[TBL] [Abstract][Full Text] [Related]
19. Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy.
Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Kokorovic A; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Eur Urol Focus; 2023 Jan; 9(1):125-132. PubMed ID: 35918270
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
